EXCLUSIVE-Warburg and Advent in the lead to acquire Baxter’s biopharma unit-sources
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
A private equity consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire medical device maker Baxter International Inc’s biopharma solutions business in a deal that could reach or exceed $4 billion, people familiar with the matter said on Sunday.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-942149588-c1f08ddba9c4491eb02bd6c1a76b0117.jpg "How to Cope with 10 Coworker Personality Types")
